Using RNA-seq to compare and identify transcriptional variants between matched pairs of carboplatin and paclitaxel-treated vs. control patient-derived xenograft (PDX) models of ovarian cancer, Dobbin and colleagues identified S1P signaling in the top three most transcriptionally altered pathways following chemotherapy treatment[27]. This evidence concerns the gene MBTPS1 and ovarian cancer.